You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscarinic M1 Receptor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

RWE About QOL and Compliance of Patients With OFS in China

Not yet recruiting
  • Breast Cancer
  • +2 more
  • 3M GnRHa
  • 1M GnRHa
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 15, 2021

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

A Retrospective rEal-life daTa Study to Assess exaceRbations and

Completed
  • COPD
  • COPD Exacerbation
    • Thessaloniki, Greece
      Papanikolaou Hospital of Thessaloniki
    Sep 7, 2022

    Estrogen-receptor Positive Premenopausal Early Breast Cancer

    Active, not recruiting
    • Early Breast Cancer
    • None intervention (observational study)
    • Aviano, Italy
    • +39 more
    Feb 7, 2023

    Tumors Trial in Worldwide (GSK525762, Placebo, Fulvestrant)

    Completed
    Has Results
    • Neoplasms
    • Birmingham, Alabama
    • +38 more
    Nov 18, 2021

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New Haven, Connecticut
    • +4 more
    Jan 27, 2023

    Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

    Active, not recruiting
    • Breast Neoplasms
    • +7 more
    • Goodyear, Arizona
    • +38 more
    Jun 29, 2022

    Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

    Not yet recruiting
    • Breast Cancer
    • Jonesboro, Arkansas
    • +142 more
    Oct 31, 2023

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

      Recruiting
      • Breast Cancer
      • Bowral, New South Wales, Australia
      • +37 more
      Aug 8, 2022

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

      Active, not recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +20 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 12, 2022

      Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

      Recruiting
      • Neuroendocrine Neoplasm
      • Biospecimen Collection
      • +4 more
      • Duarte, California
      • +3 more
      Jan 12, 2023

      Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast

      Terminated
      Has Results
      • Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
      • Phoenix, Arizona
      • +39 more
      Jun 21, 2022

      Breast Cancer Trial in Worldwide (Amcenestrant, Palbociclib, Alpelisib)

      Active, not recruiting
      • Breast Cancer
      • Denver, Colorado
      • +30 more
      Aug 18, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

      Active, not recruiting
      • BRCA1 Gene Mutation
      • +9 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Sep 16, 2022

      Select Advanced Solid Tumors Trial in Canada, United Kingdom, United States (IMCnyeso)

      Terminated
      Has Results
      • Select Advanced Solid Tumors
      • Aurora, Colorado
      • +11 more
      Mar 9, 2022

      Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

      Recruiting
      • Locally Advanced (Inoperable) or Metastatic Breast Cancer
      • Los Angeles, California
      • +76 more
      Nov 25, 2022

      Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

      Recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +13 more
      • Bintrafusp Alfa
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 14, 2022

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

      Recruiting
      • Hepatitis B, Chronic
      • Vancouver, British Columbia, Canada
      • +31 more
      Jan 17, 2023

      Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

      Active, not recruiting
      • Breast Cancer
      • Atlanta, Georgia
      • +19 more
      Dec 5, 2022

      Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial

      Recruiting
      • Familial Hypercholesterolemia
      • +7 more
      • Research-based genetic test for Familial Hypercholesterolemia
      • Vancouver, British Columbia, Canada
      • +1 more
      Jan 31, 2022

      Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)

      Recruiting
      • Solid Tumor
      • Farletuzumab ecteribulin
      • Tucson, Arizona
      • +26 more
      Jan 30, 2023

      Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and

      Completed
      • Microsatellite Stable Colorectal Carcinoma
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Mar 30, 2021